| Primary |
| Vitamin Supplementation |
23.7% |
| Flatulence |
13.2% |
| Gastrooesophageal Reflux Disease |
10.5% |
| Dyspepsia |
7.9% |
| Diarrhoea |
5.3% |
| Gastric Disorder |
5.3% |
| Gastritis |
5.3% |
| Ulcer |
5.3% |
| Abdominal Pain Upper |
2.6% |
| Anticoagulant Therapy |
2.6% |
| Arthritis |
2.6% |
| Blood Cholesterol Increased |
2.6% |
| Gallbladder Disorder |
2.6% |
| Hot Flush |
2.6% |
| Hyperchlorhydria |
2.6% |
| Hypertension |
2.6% |
| Thyroid Disorder |
2.6% |
|
| Therapeutic Response Unexpected |
23.5% |
| Off Label Use |
17.6% |
| Amnesia |
5.9% |
| Death |
5.9% |
| Depression |
5.9% |
| Medication Error |
5.9% |
| Pleurisy |
5.9% |
| Product Packaging Issue |
5.9% |
| Pulmonary Oedema |
5.9% |
| Sleep Apnoea Syndrome |
5.9% |
| Underdose |
5.9% |
| Wrong Technique In Drug Usage Process |
5.9% |
|
| Secondary |
| Product Used For Unknown Indication |
23.2% |
| Dyspepsia |
11.9% |
| Gastrooesophageal Reflux Disease |
10.8% |
| Pain |
9.2% |
| Drug Use For Unknown Indication |
8.6% |
| Flatulence |
4.3% |
| Wolff-parkinson-white Syndrome |
3.8% |
| Abdominal Pain Upper |
3.2% |
| Duodenal Ulcer |
2.7% |
| Hypertension |
2.7% |
| Anxiety |
2.2% |
| Asthma |
2.2% |
| Constipation |
2.2% |
| Diabetes Mellitus |
2.2% |
| Drug Dependence |
2.2% |
| Ulcer |
2.2% |
| Convulsion |
1.6% |
| Depression |
1.6% |
| Diverticulitis |
1.6% |
| Infection Prophylaxis |
1.6% |
|
| Faeces Discoloured |
9.3% |
| Oedema Peripheral |
9.3% |
| Weight Decreased |
9.3% |
| White Blood Cell Count Increased |
9.3% |
| Nausea |
7.0% |
| Pancreatitis Acute |
7.0% |
| Scleral Discolouration |
7.0% |
| Nephrolithiasis |
4.7% |
| Product Quality Issue |
4.7% |
| Therapeutic Response Unexpected |
4.7% |
| Underweight |
4.7% |
| Vomiting |
4.7% |
| Abdominal Discomfort |
2.3% |
| Constipation |
2.3% |
| Cytolytic Hepatitis |
2.3% |
| Death |
2.3% |
| Diarrhoea |
2.3% |
| Drug Ineffective |
2.3% |
| Gastric Disorder |
2.3% |
| Gastrooesophageal Reflux Disease |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
30.9% |
| Product Used For Unknown Indication |
13.6% |
| Pain |
8.0% |
| Gastrooesophageal Reflux Disease |
5.3% |
| Hypertension |
4.7% |
| Prophylaxis |
4.5% |
| Depression |
4.2% |
| Dyspepsia |
3.5% |
| Constipation |
3.3% |
| Nausea |
2.9% |
| Rheumatoid Arthritis |
2.8% |
| Insomnia |
2.6% |
| Anxiety |
2.3% |
| Arthritis |
1.8% |
| Headache |
1.8% |
| Non-small Cell Lung Cancer |
1.7% |
| Back Pain |
1.6% |
| Gastric Ulcer |
1.6% |
| Renal Transplant |
1.6% |
| Diabetes Mellitus |
1.5% |
|
| Vomiting |
11.4% |
| Weight Decreased |
10.0% |
| Urinary Tract Infection |
9.0% |
| Pancreatitis Acute |
6.9% |
| Pneumonia |
5.9% |
| Weight Increased |
5.2% |
| Thrombocytopenia |
4.8% |
| Withdrawal Syndrome |
4.5% |
| Pain |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Interstitial Lung Disease |
3.8% |
| Rhabdomyolysis |
3.8% |
| Rash |
3.5% |
| Tremor |
3.5% |
| Tumour Lysis Syndrome |
3.5% |
| Wound Infection |
3.5% |
| Death |
3.1% |
| Off Label Use |
3.1% |
| Renal Failure Acute |
3.1% |
| Walking Aid User |
3.1% |
|
| Interacting |
| Abdominal Discomfort |
100.0% |
|
| Blood Potassium Increased |
25.0% |
| Faeces Discoloured |
25.0% |
| Lipase Increased |
25.0% |
| Presyncope |
25.0% |
|
